Federal judge denies Amgen’s motion to dismiss Regeneron antitrust case

While Amgen and Regeneron’s spat before the Supreme Court goes forward on Amgen’s request to revive patents on its blockbuster Repatha and block the sale of Sanofi and Regeneron’s Praluent, another case is moving forward in federal court — this time Regeneron is pushing a case against Amgen and…